|
Report No. : |
302313 |
|
Report Date : |
12.01.2015 |
IDENTIFICATION DETAILS
|
Name : |
ZYDUS
HOSPIRA ONCOLOGY PRIVATE LIMITED (w.e.f.12.10.2007) |
|
|
|
|
Formerly Known
As : |
ZYDUS MAYNE ONCOLOGY PRIVATE LIMITED |
|
|
|
|
Registered
Office : |
Plot No.3, Pharmez, Special Economic Zone, |
|
|
|
|
Country : |
India |
|
|
|
|
Financials (as on)
: |
31.03.2014 |
|
|
|
|
Date of
Incorporation : |
13.06.2005 |
|
|
|
|
Com. Reg. No.: |
04-046246 |
|
|
|
|
Capital
Investment / Paid-up Capital : |
Rs.150.000 Millions |
|
|
|
|
CIN No.: [Company Identification
No.] |
U24230GJ2005PTC046246 |
|
|
|
|
IEC No.: |
Not Available |
|
|
|
|
TAN No.: [Tax Deduction &
Collection Account No.] |
AHMZ00175A |
|
|
|
|
PAN No.: [Permanent Account No.] |
AAACZ2327A |
|
|
|
|
Legal Form : |
Private Limited Liability Company |
|
|
|
|
Line of Business
: |
Manufacturer and Exporter of Pharmaceutical Products. |
|
|
|
|
No. of Employees
: |
260 (Approximately) |
RATING & COMMENTS
|
MIRA’s Rating : |
A (63) |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
Status : |
Good |
|
|
|
|
Payment Behaviour : |
Regular |
|
|
|
|
Litigation : |
Clear |
|
|
|
|
Comments : |
Subject is a joint venture between Cadila Healthcare Limited and
Hospira Australia Pty Limited. It is an established company having fine track record. Financial position
of the company is sound. Fundamentals of the company’s are strong and
healthy. Trade relations are fair. Business is active. Payments are reported to
be regular and as per commitment. The company can be considered good for normal business dealings at
usual trade terms and conditions. |
NOTES :
Any query related to this report can be made
on e-mail : infodept@mirainform.com
while quoting report number, name and date.
EXTERNAL AGENCY RATING
|
Rating Agency Name |
CRISIL |
|
Rating |
Long Term = (AA-) |
|
Rating Explanation |
High Degree of Safety and Very Low Credit. |
|
Date |
12.05.2014 |
RBI DEFAULTERS’ LIST STATUS
Subject’s name is not enlisted as a defaulter in
the publicly available RBI Defaulters’ list.
EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS
Subject’s name is not enlisted as a defaulter
in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of
31-03-2014.
INFORMATION PARTED BY
|
Name : |
Mr. Jayesh Patel |
|
Designation : |
Senior Finance Manager |
|
Contact No.: |
91-2717-663000 |
|
Date : |
08.01.2015 |
LOCATIONS
|
Registered Office / Factory : |
Plot No.3, Pharmez, Special Economic Zone, |
|
Tel. No.: |
91-2717-663000/ 663211 / 106 |
|
Mobile No.: |
91-9724307940 (Mr. Jayesh Patel) |
|
Fax No.: |
91-2717-663100 |
|
E-Mail : |
|
|
Area : |
3866 Sq. Mt. |
|
Location : |
Leased |
DIRECTORS
As on 01.08.2014
|
Name : |
Mr. Omprakash R. Arya |
|
Designation : |
Managing Director |
|
Address : |
12, Ishan Apartments, Brahmin Mitra Mandal Society, Ellisbridge,
Ahmedabad – 380006, |
|
Date of Birth/Age : |
01.03.1950 |
|
Qualification |
M. Sc. |
|
Experience : |
34 years |
|
Date of Appointment : |
01.02.2006 |
|
DIN No. : |
00146677 |
|
Voter ID No.: |
IIE 1621093 |
|
|
|
|
Name : |
Mr. Ganesh N. Nayak |
|
Designation : |
Director |
|
Address : |
3, Ashwamegh Part V, |
|
Date of Birth/Age : |
18.05.1955 |
|
Date of Appointment : |
24.01.2006 |
|
DIN No. : |
00017481 |
|
|
|
|
Name : |
Mr. Shirtishkumar G. Belapure |
|
Designation : |
Director |
|
Address : |
3, Amramanjari Bungalow, Opposite Chitvan Plor, |
|
Date of Birth/Age : |
19.07.1953 |
|
Date of Appointment : |
16.07.2008 |
|
DIN No. : |
02219458 |
|
Voter ID No.: |
MT/09/045/107601 |
|
|
|
|
Name : |
Mr. Arthur J. Flocco JR |
|
Designation : |
Director |
|
Address : |
305, |
|
Date of Birth/Age : |
12.08.1957 |
|
Date of Appointment : |
22.07.2009 |
|
DIN No. : |
02634539 |
|
|
|
|
Name : |
Richard John Davies |
|
Designation : |
Director |
|
Address : |
331, Sheridan Road, Winnetka IL U.S - 600934227 |
|
Date of Birth/Age : |
26.06.1961 |
|
Date of Appointment : |
02.05.2013 |
|
DIN No. : |
06568148 |
|
|
|
|
Name : |
Mr. Bhaktavatsala Canakapalli Rao |
|
Designation : |
Chairman cum Managing Director (w.e.f. 25.01.2011) |
|
Address : |
No. 9, Old No. 6, Lakshmanan Street, Mahalingapuram, Nungambakkam,
Chennai – 600034, Tamilnadu, India |
|
Date of Birth/Age : |
10.08.1949 |
|
Date of Appointment : |
15.04.2010 |
|
DIN No. : |
00010175 |
|
|
|
|
Name : |
Mr. Matthew Robert Stober |
|
Designation : |
Director |
|
Address : |
6848 Piershill Lane, Cary, NC - 27519, US |
|
Date of Birth/Age : |
20.06.1967 |
|
Date of Appointment : |
11.02.2014 |
|
DIN No. : |
06796590 |
|
|
|
|
Name : |
Mr. Nitinkumar Dalsukhray Parekh |
|
Designation : |
Director |
|
Address : |
A-3, Aryaman Bungalows, Near Railway Crossing, Thaltej – Shilaj Road,
Ahmedabad – 380015, Gujarat, India |
|
Date of Birth/Age : |
09.02.1961 |
|
Date of Appointment : |
11.02.2014 |
|
DIN No. : |
00155570 |
KEY EXECUTIVES
|
Name : |
Mr. Umesh Vinodchandra Parikh |
|
Designation : |
Vice President-Finance and Company Secretary |
|
Address : |
B-7, Jineshwar Nagar Part-I, Near Gyanjyot School, Ranna Park,
Ghatlodia, Ahmedabad – 380061, Gujarat, India |
|
Date of Birth/Age : |
27.05.1968 |
|
Date of Appointment : |
17.11.2005 |
|
PAN No.: |
ACCPP4496R |
MAJOR SHAREHOLDERS
As on 01.08.2014
|
Names of Shareholders |
|
No. of Shares |
|
Hospira Australia Pty Limited, Australia |
|
7500000 |
|
Cadila Healthcare Limited, India |
|
7500000 |
|
|
|
|
|
Total |
|
15000000 |

As on 01.08.2014
Equity Share Break up (Percentage of Total Equity)
|
Category |
Percentage |
|
Foreign holdings( Foreign institutional investor(s),
Foreign companie(s) Foreign financial institution(s), Non-resident Indian(s)
or Overseas Corporate bodies or Others |
50.00 |
|
Bodies corporate |
50.00 |
|
Total |
100.00 |
BUSINESS DETAILS
|
Line of Business : |
Manufacturer and Exporter of Pharmaceutical Products. |
||||||
|
|
|
||||||
|
Products : |
|
||||||
|
|
|
||||||
|
Brand Names : |
Not Available |
||||||
|
|
|
||||||
|
Agencies Held : |
Not Available |
||||||
|
|
|
||||||
|
Exports : |
|
||||||
|
Products : |
Pharmaceutical Products |
||||||
|
Countries : |
|
||||||
|
|
|
||||||
|
Imports : |
|
||||||
|
Products : |
Raw Materials |
||||||
|
Countries : |
|
||||||
|
|
|
||||||
|
Terms : |
|
||||||
|
Selling : |
Cash and Advance Payment (60 Days) |
||||||
|
|
|
||||||
|
Purchasing : |
Cash and Advance Payment (30/60 Days) |
PRODUCTION STATUS = NOT AVAILABLE
GENERAL INFORMATION
|
Suppliers : |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Customers : |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
No. of Employees : |
260 (Approximately) |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Bankers : |
|
|
Auditors : |
|
|
Name : |
B S R and Company Chartered Accountants |
|
Address : |
Lodha Excelus, 1st,
Floor, Apollo mills compound, N M Joshi Marg, Mahalaxmi, Mumbai – 400011,
Maharashtra, India |
|
PAN
No. : |
AAAFB9852F |
|
|
|
|
Memberships : |
Not Available |
|
|
|
|
Collaborators : |
Not Available |
|
|
|
|
Joint Ventures : |
· Cadila Healthcare Limited, Australia CIN No: L24230GJ1995PLC025878 ·
Hospira Australia Pty Limited, |
CAPITAL STRUCTURE
As on 01.08.2014
|
No. of Shares |
Type |
Value |
Amount |
|
|
|
|
|
|
15000000 |
Equity Shares |
Rs.10/- each |
Rs.150.000 Millions |
|
5000 |
Preference Shares |
Rs. 100000/- each |
Rs.500.000 Millions |
|
|
|
|
|
|
|
Total |
|
Rs.650.000
Millions |
Issued, Subscribed & Paid-up Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
|
|
|
|
|
15000000 |
Equity Shares |
Rs.10/- each |
Rs.150.000 Millions |
|
|
|
|
|
FINANCIAL DATA
[all figures are
in Rupees Millions]
ABRIDGED BALANCE
SHEET
|
SOURCES
OF FUNDS |
31.03.2014 |
31.03.2013 |
31.03.2012 |
|
|
|
|
|
|
I.
EQUITY AND LIABILITIES |
|
|
|
|
(1)Shareholders' Funds |
|
|
|
|
(a) Share Capital |
150.000 |
150.000 |
150.000 |
|
(b) Reserves & Surplus |
3088.810 |
2859.830 |
3088.550 |
|
(c) Money received against share
warrants |
0.000 |
0.000 |
0.000 |
|
|
|
|
|
|
(2) Share Application money
pending allotment |
0.000 |
0.000 |
0.000 |
|
Total
Shareholders’ Funds (1) + (2) |
3238.810 |
3009.830 |
3238.550 |
|
|
|
|
|
|
(3) Non-Current Liabilities |
|
|
|
|
(a) long-term borrowings |
0.000 |
0.000 |
0.000 |
|
(b) Deferred tax liabilities
(Net) |
18.690 |
0.000 |
0.000 |
|
(c) Other long term
liabilities |
5.960 |
1.280 |
0.280 |
|
(d) long-term provisions |
8.570 |
7.560 |
6.900 |
|
Total
Non-current Liabilities (3) |
33.220 |
8.840 |
7.180 |
|
|
|
|
|
|
(4) Current Liabilities |
|
|
|
|
(a) Short term borrowings |
0.000 |
0.000 |
0.000 |
|
(b) Trade payables |
245.330 |
113.550 |
142.120 |
|
(c) Other current liabilities |
24.410 |
31.580 |
47.090 |
|
(d) Short-term provisions |
1304.780 |
3952.650 |
104.150 |
|
Total
Current Liabilities (4) |
1574.520 |
4097.780 |
293.360 |
|
|
|
|
|
|
TOTAL |
4846.550 |
7116.450 |
3539.090 |
|
|
|
|
|
|
II.
ASSETS |
|
|
|
|
(1) Non-current assets |
|
|
|
|
(a) Fixed Assets |
|
|
|
|
(i) Tangible assets |
656.520 |
646.020 |
685.770 |
|
(ii) Intangible Assets |
6.120 |
7.090 |
8.930 |
|
(iii) Capital work-in-progress |
501.610 |
113.010 |
28.690 |
|
(iv) Intangible assets under
development |
0.000 |
0.000 |
0.000 |
|
(b) Non-current Investments |
0.000 |
0.000 |
0.000 |
|
(c) Deferred tax assets (net) |
0.000 |
0.000 |
0.000 |
|
(d) Long-term Loan and Advances |
565.530 |
77.610 |
32.440 |
|
(e) Other Non-current assets |
0.000 |
0.000 |
0.000 |
|
Total
Non-Current Assets |
1729.780 |
843.730 |
755.830 |
|
|
|
|
|
|
(2) Current assets |
|
|
|
|
(a) Current investments |
375.480 |
1596.330 |
60.780 |
|
(b) Inventories |
1212.460 |
533.700 |
560.840 |
|
(c) Trade receivables |
728.530 |
1298.450 |
1619.830 |
|
(d) Cash and cash equivalents |
724.030 |
2816.690 |
526.290 |
|
(e) Short-term loans and
advances |
15.410 |
14.520 |
10.780 |
|
(f) Other current assets |
60.860 |
13.030 |
4.740 |
|
Total
Current Assets |
3116.770 |
6272.720 |
2783.260 |
|
|
|
|
|
|
TOTAL |
4846.550 |
7116.450 |
3539.090 |
PROFIT & LOSS
ACCOUNT
|
|
PARTICULARS |
31.03.2014 |
31.03.2013 |
31.03.2012 |
|
|
SALES |
|
|
|
|
|
Income |
|
|
|
|
|
Other Income |
|
|
|
|
|
TOTAL
(A) |
4549.960 |
6882.500 |
5928.200 |
|
|
|
|
|
|
|
Less |
TOTAL EXPENSES |
1834.300 |
2151.350 |
1418.930 |
|
|
|
|
|
|
|
Less |
PROFIT/
(LOSS) BEFORE INTEREST, TAX, DEPRECIATION
AND AMORTISATION (C) |
2715.660 |
4731.150 |
4509.270 |
|
|
|
|
|
|
|
Less |
FINANCIAL
EXPENSES (D) |
0.000 |
0.000 |
21.470 |
|
|
|
|
|
|
|
|
PROFIT
/ (LOSS) BEFORE TAX, DEPRECIATION AND AMORTISATION (C-D) (E) |
2715.660 |
4731.150 |
4487.800 |
|
|
|
|
|
|
|
Less/
Add |
DEPRECIATION/
AMORTISATION (F) |
83.230 |
80.670 |
74.870 |
|
|
|
|
|
|
|
|
PROFIT/
(LOSS) BEFORE TAX (E-F) (G) |
2632.430 |
4650.480 |
4412.930 |
|
|
|
|
|
|
|
Less |
TAX
(I) |
34.300 |
930.620 |
870.170 |
|
|
|
|
|
|
|
|
PROFIT/
(LOSS) AFTER TAX (G-I)
(J) |
2598.130 |
3719.860 |
3542.760 |
|
|
|
|
|
|
|
Add |
PREVIOUS
YEARS’ BALANCE BROUGHT FORWARD (K) |
1442.110 |
2042.810 |
370.070 |
|
|
|
|
|
|
|
Less |
APPROPRIATIONS |
|
|
|
|
|
Transfer to General Reserve |
259.810 |
371.980 |
354.280 |
|
|
Dividend |
188.640 |
573.580 |
960.000 |
|
|
Tax on Dividend |
1110.000 |
3375.000 |
155.740 |
|
|
Transfer to capital redemption
reserves |
0.000 |
0.000 |
400.000 |
|
|
Total
(M) |
1558.450 |
4320.560 |
1870.020 |
|
|
|
|
|
|
|
|
Balance
Carried to the B/S (J+K+L-M) |
1411.280 |
1442.110 |
2042.810 |
|
|
|
|
|
|
|
|
EARNINGS
IN FOREIGN CURRENCY |
|
|
|
|
|
F.O.B. Value of Exports |
2879.950 |
7032.240 |
7034.620 |
|
|
TOTAL
EARNINGS |
2879.950 |
7032.240 |
7034.620 |
|
|
|
|
|
|
|
|
Earnings
/ (Loss) Per Share (Rs.) |
173.21 |
247.99 |
236.18 |
KEY RATIOS
|
PARTICULARS |
|
31.03.2014 |
31.03.2013 |
31.03.2012 |
|
Net Profit Margin (PAT/Sales) |
(%) |
57.10 |
54.05 |
59.76 |
|
|
|
|
|
|
|
Operating Profit Margin (PBDIT / Sales) |
(%) |
0.00 |
0.00 |
76.06 |
|
|
|
|
|
|
|
Return on Total Assets (PBT/Total Assets} |
(%) |
60.59 |
66.40 |
125.71 |
|
|
|
|
|
|
|
Return on Investment (ROI) (PBT/Networth) |
|
0.81 |
1.55 |
1.36 |
|
|
|
|
|
|
|
Current Ratio (Current Asset/Current Liability) |
|
1.98 |
1.53 |
9.49 |
FINANCIAL ANALYSIS
[all figures are
in Rupees Millions]
DEBT EQUITY RATIO
|
Particular |
31.03.2012 |
31.03.2013 |
31.03.2014 |
|
|
(Rs.
In Millions) |
(Rs.
In Millions) |
(Rs.
In Millions) |
|
Share Capital |
150.000 |
150.000 |
150.000 |
|
Reserves & Surplus |
3088.550 |
2859.830 |
3088.810 |
|
Net
worth |
3238.550 |
3009.830 |
3238.810 |
|
|
|
|
|
|
long-term borrowings |
0.000 |
0.000 |
0.000 |
|
Short term borrowings |
0.000 |
0.000 |
0.000 |
|
Total
borrowings |
0.000 |
0.000 |
0.000 |
|
Debt/Equity
ratio |
0.000 |
0.000 |
0.000 |

YEAR-ON-YEAR GROWTH
|
Year
on Year Growth |
31.03.2012 |
31.03.2013 |
31.03.2014 |
|
|
(Rs.
In Millions) |
(Rs.
In Millions) |
(Rs.
In Millions) |
|
Total Income |
5928.200 |
6882.500 |
4549.960 |
|
|
|
16.098 |
(33.891) |

NET PROFIT MARGIN
|
Net
Profit Margin |
31.03.2012 |
31.03.2013 |
31.03.2014 |
|
|
(Rs.
In Millions) |
(Rs.
In Millions) |
(Rs.
In Millions) |
|
Total Income |
5928.200 |
6882.500 |
4549.960 |
|
Profit |
3542.760 |
3719.860 |
2598.130 |
|
|
59.76% |
54.05% |
57.10% |

LOCAL AGENCY FURTHER INFORMATION
CURRENT MATURITY
OF LONG TERM DEBT – NOT AVAILABLE
|
Sr. No. |
Check List by Info Agents |
Available in
Report (Yes / No) |
|
1] |
Year of Establishment |
Yes |
|
2] |
Locality of the firm |
Yes |
|
3] |
Constitutions of the firm |
Yes |
|
4] |
Premises details |
Yes |
|
5] |
Type of Business |
Yes |
|
6] |
Line of Business |
Yes |
|
7] |
Promoter's background |
Yes |
|
8] |
No. of employees |
Yes |
|
9] |
Name of person contacted |
Yes |
|
10] |
Designation of contact
person |
Yes |
|
11] |
Turnover of firm for last
three years |
Yes |
|
12] |
Profitability for last
three years |
Yes |
|
13] |
Reasons for variation
<> 20% |
---------------------- |
|
14] |
Estimation for coming
financial year |
No |
|
15] |
Capital in the business |
Yes |
|
16] |
Details of sister
concerns |
Yes |
|
17] |
Major suppliers |
No |
|
18] |
Major customers |
No |
|
19] |
Payments terms |
Yes |
|
20] |
Export / Import details (if
applicable) |
Yes |
|
21] |
Market information |
---------------------- |
|
22] |
Litigations that the firm
/ promoter involved in |
---------------------- |
|
23] |
Banking Details |
Yes |
|
24] |
Banking facility details |
Yes |
|
25] |
Conduct of the banking
account |
---------------------- |
|
26] |
Buyer visit details |
---------------------- |
|
27] |
Financials, if provided |
Yes |
|
28] |
Incorporation details, if
applicable |
Yes |
|
29] |
Last accounts filed at
ROC |
Yes |
|
30] |
Major Shareholders, if
available |
Yes |
|
31] |
Date of Birth of
Proprietor/Partner/Director, if available |
Yes |
|
32] |
PAN of
Proprietor/Partner/Director, if available |
Yes |
|
33] |
Voter ID No of
Proprietor/Partner/Director, if available |
Yes |
|
34] |
External Agency Rating,
if available |
Yes |
Note:
Registered office of the company has been shifted from
Gandhi Nagar Highway, Ahmedabad – 380015, Gujarat, India India to the present
address w.e.f.19.07.2007
BACKGROUND
The Company is a
Joint Venture between Cadila Healthcare Limited and Hospira Australia Pty
Limited, incorporated in Australia. The Company is manufacturing anti-cancer
formulations in Pharmez, Special Economic Zone near Ahmedabad. The Company had
started the commercial production on 1 May 2009.
INDEX OF CHARGES
|
S.No. |
Charge ID |
Date of Charge
Creation/Modification |
Charge amount
secured |
Charge Holder |
Address |
Service Request
Number (SRN) |
|
1 |
10518982 |
26/08/2014 |
600,000,000.00 |
ICICI Bank Limited |
9th Floor, JMC House, Opp. Parimal Garden, Ambawadi, Ahmedabad, Gujarat - 380006, INDIA |
C19737519 |
|
2 |
10211370 |
11/09/2014 * |
300,000,000.00 |
Standard Chartered Bank |
ABHIJEET II, NEAR MITHAKHALI CROSS ROADS, AHMEDABAD, Gujarat - 380006, INDIA |
C22843486 |
* Date of charge modification
FIXED ASSETS
² Land
² Buildings
² Plant and Equipment
² Furniture and Fixtures
² Vehicles
² Office equipment
² Computer Equipments
CMT REPORT (Corruption, Money Laundering & Terrorism]
The Public Notice information has been collected from various sources
including but not limited to: The Courts,
1] INFORMATION ON
DESIGNATED PARTY
No exist designating subject or any of its beneficial owners, controlling
shareholders or senior officers as terrorist or terrorist organization or whom
notice had been received that all financial transactions involving their assets
have been blocked or convicted, found guilty or against whom a judgement or
order had been entered in a proceedings for violating money-laundering,
anti-corruption or bribery or international economic or anti-terrorism sanction
laws or whose assets were seized, blocked, frozen or ordered forfeited for
violation of money laundering or international anti-terrorism laws.
2] Court Declaration :
No exist to suggest that subject is or was
the subject of any formal or informal allegations, prosecutions or other
official proceeding for making any prohibited payments or other improper
payments to government officials for engaging in prohibited transactions or
with designated parties.
3] Asset Declaration :
No records exist to suggest that the property or assets of the subject
are derived from criminal conduct or a prohibited transaction.
4] Record on Financial
Crime :
Charges or conviction
registered against subject: None
5] Records on Violation of
Anti-Corruption Laws :
Charges or
investigation registered against subject: None
6] Records on Int’l
Anti-Money Laundering Laws/Standards :
Charges or
investigation registered against subject: None
7] Criminal Records
No
available information exist that suggest that subject or any of its principals
have been formally charged or convicted by a competent governmental authority for
any financial crime or under any formal investigation by a competent government
authority for any violation of anti-corruption laws or international anti-money
laundering laws or standard.
8] Affiliation with
Government :
No record
exists to suggest that any director or indirect owners, controlling
shareholders, director, officer or employee of the company is a government
official or a family member or close business associate of a Government
official.
9] Compensation Package :
Our market
survey revealed that the amount of compensation sought by the subject is fair
and reasonable and comparable to compensation paid to others for similar
services.
10] Press Report :
No press reports / filings exists on
the subject.
CORPORATE GOVERNANCE
MIRA INFORM as part of its Due Diligence do provide comments on
Corporate Governance to identify management and governance. These factors often
have been predictive and in some cases have created vulnerabilities to credit
deterioration.
Our Governance Assessment focuses principally on the interactions
between a company’s management, its Board of Directors, Shareholders and other
financial stakeholders.
CONTRAVENTION
Subject is not known to have contravened any existing local laws, regulations
or policies that prohibit, restrict or otherwise affect the terms and
conditions that could be included in the agreement with the subject.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.62.39 |
|
|
1 |
Rs.94.17 |
|
Euro |
1 |
Rs.73.61 |
INFORMATION DETAILS
|
Information
Gathered by : |
SVA |
|
|
|
|
Analysis Done by
: |
DIV |
|
|
|
|
Report Prepared
by : |
ART |
SCORE & RATING EXPLANATIONS
|
SCORE FACTORS |
RANGE |
POINTS |
|
HISTORY |
1~10 |
7 |
|
PAID-UP CAPITAL |
1~10 |
7 |
|
OPERATING SCALE |
1~10 |
7 |
|
FINANCIAL
CONDITION |
|
|
|
--BUSINESS SCALE |
1~10 |
7 |
|
--PROFITABILITY |
1~10 |
7 |
|
--LIQUIDITY |
1~10 |
7 |
|
--LEVERAGE |
1~10 |
7 |
|
--RESERVES |
1~10 |
7 |
|
--CREDIT LINES |
1~10 |
7 |
|
--MARGINS |
-5~5 |
-- |
|
DEMERIT POINTS |
|
|
|
--BANK CHARGES |
YES/NO |
YES |
|
--LITIGATION |
YES/NO |
NO |
|
--OTHER ADVERSE INFORMATION |
YES/NO |
NO |
|
MERIT POINTS |
|
|
|
--SOLE DISTRIBUTORSHIP |
YES/NO |
YES |
|
--EXPORT ACTIVITIES |
YES/NO |
YES |
|
--AFFILIATION |
YES/NO |
YES |
|
--LISTED |
YES/NO |
NO |
|
--OTHER MERIT FACTORS |
YES/NO |
YES |
|
DEFAULTER
|
|
|
|
--RBI |
YES/NO |
NO |
|
--EPF |
YES/NO |
NO |
|
TOTAL |
|
63 |
This score serves as a reference to assess SC’s
credit risk and to set the amount of credit to be extended. It is calculated
from a composite of weighted scores obtained from each of the major sections of
this report. The assessed factors and their relative weights (as indicated
through %) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend (10%) Operational size
(10%)
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit transaction.
It has above average (strong) capability for payment of interest and
principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively below
average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
-- |
NB |
New Business |
-- |
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or
its officials.